logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Global risk assets fell sharply, scaring gold buyers! Gold prices stabilized and rebounded after a steep decline.

date
05/11/2025
According to the Securities Times APP, after experiencing the largest single-day decline in more than a week, gold rebounded, as the overall risk aversion sentiment in the financial markets boosted demand for safe-haven assets.
Latest
3 m ago
According to Kyodo News, American steel company plans to invest $11 billion in Nippon Steel Corporation's new capital plan by 2028.
4 m ago
The company Super Micro Computer (SMCI.US) failed to meet expectations for the sixth consecutive quarter, causing its stock price to plummet after hours.
4 m ago
Court documents show: Alphabet's subsidiary Google has reached a settlement with the U.S. court to resolve the anti-trust lawsuit filed by Epic Games, the developer of "Fortnite," against its app store.
5 m ago
Lunchtime Announcement: Yingli Corporation's Asset Acquisition and Supplementary Fundraising Application has been accepted.
6 m ago
Shanghai Laisi (002252.SZ): SR604 Injection New Indications Obtained Drug Clinical Trial Approval.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.